-
Impact of Cardiovascular, Renal and Metabolic Comorbidities on Activity and Health-Related Quality of Life in Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada
Mar 10, 2025, 14:00 PM -
Tinnitus Risk After XBB.1.5 COVID-19 Vaccination: A Self-Controlled Case Series Study
Mar 10, 2025, 14:00 PM -
Understanding Barriers to the Early Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease from the Perspective of Physicians and Patients: Results from a Real-World Survey in Germany
Mar 10, 2025, 14:00 PM -
Uptake of national guidance for prescribing of SGLT-2 inhibitors for type 2 diabetes in the UK
Mar 10, 2025, 14:00 PM -
Developing a Large Language Model-Based Simulation for P&T Committees: Methodology and Inputs for Realistic Dynamics
Mar 10, 2025, 14:00 PM -
Cost-per-Event Analysis of Risankizumab in Comparison to Ustekinumab for the Treatment of Patients With Moderate-to-Severe Crohn’s Disease in Brazil
Mar 10, 2025, 14:00 PM -
ActiveSLR: Optimizing efficiency in Systematic Literature Reviews with Artificial Intelligence
Mar 10, 2025, 14:00 PM -
A Descriptive Analysis of Key Findings From the 2024-2025 ISPOR Student Interest Survey
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Lanadelumab Versus C1 Inhibitor for Hereditary Angioedema Long Term Prophylaxis: A Brazilian Private Sector Perspective
Mar 10, 2025, 14:00 PM -
Predicted Effectiveness of First- and Second-Line Treatment Sequences in Advanced or Recurrent Endometrial Cancer
Mar 10, 2025, 14:00 PM -
2025 Review of Gene Therapy Access Landscape
Mar 10, 2025, 14:00 PM -
Cost Effectiveness of Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients in China
Mar 10, 2025, 14:00 PM -
Treatment Patterns Post-CAR T Cell Therapy in Patients With Hematologic Malignancies: A Real-World US Study
Mar 10, 2025, 14:00 PM -
Revisiting Archetypes: New Archetypes for Strategic Global Value Evidence Planning
Mar 10, 2025, 14:00 PM -
Nirsevimab for RSV Prevention in Hong Kong Infants: A Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
Application of Prevalent New-User Cohort Designs to a Claims Data Study of Incidence of Nutritional Deficiency in People With Diabetes Using GLP-1 Receptor Agonists
Mar 10, 2025, 14:00 PM -
Treatment Experience and Other Health and Social Characteristics Among Patients With Cancer From a Large US Population-Based Survey
Mar 10, 2025, 14:00 PM -
Disparities in COVID-19 Vaccination Uptake by Social Vulnerability Index: A US nationwide study
Mar 10, 2025, 14:00 PM -
The Impact of Meeting Orphan Criteria on Reimbursement Decisions and ICERs in Scotland
Mar 10, 2025, 14:00 PM -
Application of ML-NMR to Time-to-Event Outcomes Using Parametric Models and Flexible Parametric (Spline) Models: A Case Study Using A Simulated Dataset
Mar 10, 2025, 14:00 PM
